查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519371

2024-2032 年按产品类型、平台、处方模式、最终用户和地区分類的护理点诊断市场报告

Point-of-Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023 年，全球IMARC Group诊断市场规模达到 492 亿美元。对更快、更方便的诊断解决方案的需求不断增长，全球传染病流行率不断上升，以及技术和小型化的进步是推动市场的一些关键因素。

即时诊断市场分析：

市场成长与规模：由于大众各种慢性病的发生率不断增加，全球即时诊断市场正在经历适度成长。

主要市场驱动因素：关键因素包括护理点工具的不断发展以及对个人化医疗以改善患者治疗效果的日益关注。

主要市场趋势：主要趋势包括投资研究活动，开发先进的测试解决方案和便携式护理点测试系统，以便在偏远地区提供医疗保健服务。

地理趋势：在医疗保健产业投资不断增加的推动下，北美主导了市场。然而，由于大众慢性病发生率不断上升，亚太地区正成为成长最快的市场。

竞争格局：即时诊断行业的一些主要市场参与者包括 Abbott Laboratories、Beckman Coulter, Inc.、Becton、Dickinson and Company、F. Hoffmann-La Roche AG 等。这些公司正在投资研发 (R&D)，扩大其全球影响力，并专注于先进测试解决方案的开发。

挑战与机会：挑战包括需要高精度和经济高效的解决方案。儘管如此，人们对个人化医疗益处的认识不断提高，预计将克服这些挑战。

即时诊断市场趋势/驱动因素：

慢性病盛行率不断上升

根据世界卫生组织 (WHO) 统计，非传染性疾病（也称为慢性病）每年夺走 4,100 万人的生命，相当于全球死亡人数的 74%。全球慢性病的增加正在推动对 POC 诊断服务的需求。糖尿病、心血管疾病和呼吸系统疾病等慢性病在大众中越来越普遍，为全球医疗保健系统带来了巨大挑战。 POC 诊断为自发性检测和持续监测这些健康併发症提供了宝贵的工具，有助于及时介入和有效的疾病管理。 POC 检测的便利性和易用性进一步有助于慢性病的管理，特别是在传统实验室设施有限或无法使用的偏远或农村地区。因此，慢性病的日益普及正在推动世界各地对即时诊断的需求。

各种技术进步

技术创新和整合在支持即时诊断市场成长方面发挥着至关重要的作用。小型化、生物感测器和连接方面的倡议和研究正在催生各种智慧和便携式诊断设备和系统。这些 POC 设备可以高精度地执行各种测试，而传统的实验室方法通常无法做到这一点。它们通常还与扩展的测试选单集成，以消除对多个设备的需求并减少获取测试结果的周转时间。

该公司还计划生产尺寸紧凑并提供全面测试设施的 POC 诊断系统。主要市场参与者也与其他公司合作，提供独特且可靠的诊断解决方案，以彻底改变医疗保健服务。 Molbio Diagnostics 于 2023 年宣布与 SigTuple 合作，开发下一代支援 AI 的便携式设备，用于许多常规和诊断测试。

对个人化医疗的日益重视

大众对个人化医疗日益增长的需求正在推动市场的成长。美国国家癌症研究所 (NCI) 发起了一项大型精准医学癌症计划，以检查使用各种新型药物组合治疗儿童和成人的有效性。

此外，随着医疗保健行业正在转向更加以患者为中心的方法，个人化医疗的接受度正在促进根据患者的需求制定治疗计划。 POC 诊断在此过程中发挥关键作用，因为它提供快速且有针对性的诊断解决方案，有助于精确的疾病识别和监测。它们为患者提供了关于治疗和整体健康的保证感，这也是患者高度接受它们的原因。此外，根据 Coriell Life Sciences 的研究，证实精准医疗已达到全球采用的临界点。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球护理点诊断市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 血糖监测套件
    • 市场走向
    • 市场预测
  • 心臟代谢监测套件
    • 市场走向
    • 市场预测
  • 妊娠和生育力测试套件
    • 市场走向
    • 市场预测
  • 传染病检测试剂盒
    • 市场走向
    • 市场预测
  • 胆固醇试纸
    • 市场走向
    • 市场预测
  • 血液学检测试剂盒
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按平台

  • 侧流分析
    • 市场走向
    • 市场预测
  • 量油尺
    • 市场走向
    • 市场预测
  • 微流控
    • 市场走向
    • 市场预测
  • 分子诊断
    • 市场走向
    • 市场预测
  • 免疫测定
    • 市场走向
    • 市场预测

第 8 章：市场细分：依处方模式

  • 基于处方的测试
    • 市场走向
    • 市场预测
  • 场外测试
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 专业诊断中心
    • 市场走向
    • 市场预测
  • 居家护理
    • 市场走向
    • 市场预测
  • 研究实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格指标

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Instrumentation Laboratory
    • Johnson & Johnson
    • Nova Biomedical Corporation
    • Pts Diagnostics
    • Qiagen
    • Siemens
    • Trinity Biotech
Product Code: SR112024A2113

The global point-of-care diagnostics market size reached US$ 49.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 99.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. The increasing demand for faster and more convenient diagnostic solutions, rising prevalence of infectious diseases across the globe, and advancements in technology and miniaturization represent some of the key factors driving the market.

Point-of-Care Diagnostics Market Analysis:

Market Growth and Size: The global point-of-care diagnostics market is experiencing moderate growth, on account of the increasing occurrence of various chronic diseases among the masses.

Major Market Drivers: Key factors include the growing development of point-of-care tools and the rising focus on personalized medicine for better patient outcomes.

Key Market Trends: Major trends include investments in research activities to develop advanced testing solutions and portable point-of-care testing systems for providing healthcare services in remote areas.

Geographical Trends: North America dominates the market, driven by rising investments in the healthcare sector. However, Asia Pacific is emerging as a fastest-growing market on account of the rising occurrence of chronic diseases among the masses.

Competitive Landscape: Some of the major market players in the point-of-care diagnostics industry include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, among many others. These companies are investing in research and development (R&D), expanding their global presence, and focusing on the development of advanced testing solutions.

Challenges and Opportunities: Challenges include the need for high accuracy and cost-effective solutions. Nonetheless, the rising awareness about the benefits of personalized medicines is projected to overcome these challenges.

Point-of-Care Diagnostics Market Trends/Drivers:

The growing prevalence of chronic diseases

According to the World Health Organization (WHO), non-communicable diseases, also called chronic diseases, kill 41 million people each year, which is equivalent to 74% of all deaths globally. The global rise in chronic diseases is driving the demand for POC diagnostic services. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent among the masses, posing substantial challenges to healthcare systems worldwide. POC diagnostics offer a valuable tool for spontaneous detection and continuous monitoring of these health complications, facilitating timely interventions and effective disease management. The convenience and easy availability of POC testing further contribute to the management of chronic diseases, especially in remote or rural areas where access to traditional laboratory facilities is limited or not available. Thus, the growing prevalence of chronic diseases is driving the point-of-care diagnostics demand around the world.

Various technological advancements

Technological innovations and integration play a crucial role in supporting the point-of-care diagnostics market growth. Initiatives and research in miniaturization, biosensors, and connectivity are leading to the creation of various smart and portable diagnostic devices and systems. These POC devices can perform a wide range of tests with high accuracy, which traditional laboratory-based methods often fail to deliver. They are also often integrated with expanded test menus to eliminate the need for multiple devices and reduce turnaround time for getting the test results.

Companies are also planning to produce POC diagnostics systems which are compact in size and offer comprehensive testing facilities. Key market players are also collaborating with other firms to offer unique and reliable diagnostic solutions to revolutionize healthcare delivery. Molbio Diagnostics declared its partnership with SigTuple in 2023 to develop next-generation AI-enabled portable devices for many routine and diagnostic tests.

The growing emphasis on personalized medicine

The increasing need for personalized medicine among the masses is propelling the growth of the market. The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to examine the effectiveness of treating children and adults with various novel drug combinations.

Moreover, as the healthcare sector is transitioning towards a more patient-centric approach, the acceptance of personalized medicine is facilitating the creation of treatment plans according to the needs of patients. POC diagnostics play a pivotal part in this procedure as it offers rapid and targeted diagnostic solutions that aid in precise disease identification and monitoring. They provide a sense of assurance to patients regarding their treatment and overall wellbeing, which is also responsible for their high acceptance among patients. Moreover, according to research done by Coriell Life Sciences, it is confirmed that precision medicine has reached a global tipping position for adoption.

Point-of-Care Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global point-of-care diagnostics market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, platform, prescription mode, and end-user.

Breakup by Product Type:

Blood-Glucose Monitoring Kit

Cardio-Metabolic Monitoring Kit

Pregnancy and Fertility Testing Kit

Infectious Disease Testing Kit

Cholesterol Test Strip

Hematology Testing Kit

Others

Blood-glucose monitoring kit represents the most popular product type

The report has provided a detailed breakup and analysis of the market based on product type. This includes blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit, and others. According to the report, blood-glucose monitoring kit represented the largest segment.

Blood-glucose monitoring kits are designed to be user-friendly, allowing patients to perform tests themselves without the need for specialized medical training. The simplicity and convenience of these kits are contributing to their widespread adoption, making them accessible to a broad spectrum of patients, including those in remote or underserved areas. Moreover, blood-glucose monitoring kits are often compact and portable, enabling patients to carry them wherever they go, thereby offering a favorable point-of-care diagnostics market outlook. Furthermore, on the basis of the predictions and research by the Institute for Health Metrics and Evaluation, global diabetes cases will increase from 529 million to 1.3 billion by 2050. The US Food and Drug Administration cleared the first over-the-counter (OTC) continuous glucose monitoring system (CGM) in the US -- the Dexcom Stelo Glucose Biosensor System. This will help people with Type 2 diabetes who don't need insulin to track their blood sugar for nonmedical purposes.

Breakup by Platform:

Lateral Flow Assays

Dipsticks

Microfluidics

Molecular Diagnostics

Immunoassays

Lateral flow assays represent the leading platform

A detailed breakup and analysis of the market based on the platform has also been provided in the report. This includes lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. According to the report, lateral flow assays hold the largest point-of-care diagnostics market share.

Lateral flow assays are known for their "simplicity" and "user-friendly" design. They are easy to use, requiring minimal training for both healthcare professionals and patients. The test procedure typically involves incorporating a samples like blood, saliva, and urine to a test strip, and the results are visually interpreted through the appearance of colored lines, eliminating the need for complex laboratory equipment. They offer stability over a wide range of environmental conditions and have a long shelf life. They also require small sample volume to conduct tests. As a result, various organizations and institutions are investing in the development of advanced lateral flow assays. For example, iiCON announced in 2021 that it will support Liverpool SME to develop advanced lateral flow tests, which can be performed with and without the addition of the Nano Biosols reagent.

Breakup by Prescription Mode:

Prescription-Based Testing

OTC Testing

Prescription-based testing currently dominates the market

The report has provided a detailed breakup and analysis of the market based on prescription mode. This includes prescription-based testing and OTC testing. According to the report, prescription-based testing represented the largest segment.

Prescription-based testing involves diagnostic tests that require a healthcare professional's order or prescription before they can be performed. These tests often undergo rigorous regulatory approval processes to ensure their safety, efficacy, and accuracy. The involvement of healthcare professionals in prescribing these tests ensures appropriate medical supervision and interpretation of the results, leading to better patient care and treatment decisions. Prescription-based testing is essential for the accurate detection, staging, and monitoring of diseases such as cancer, infectious diseases, cardiovascular disorders, and autoimmune conditions. As per the reports of WHO, over 35 million new cancer cases are predicted in 2050. This will further increase the need for prescription-based testing solutions.

Breakup by End-User:

Professional Diagnostic Centers

Home Care

Research Laboratories

Others

Professional diagnostic centers account for the majority of the market share

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes professional diagnostic centers, home care, research laboratories, and others. According to the report, professional diagnostic centers accounted for the largest market share.

Professional diagnostic centers offer a wide range of POC diagnostic tests, catering to various medical specialties and healthcare needs. These centers often have advanced equipment and well-trained personnel, allowing them to perform a diverse set of tests, including blood tests, rapid infectious disease testing, urinalysis, pregnancy tests, and more. The availability of comprehensive testing services makes professional diagnostic centers a preferred choice for both patients and healthcare providers. Moreover, professional diagnostic centers are staffed by qualified healthcare professionals, including medical technologists, clinical laboratory scientists, and physicians.

According to a report by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the Asia-Pacific Trade and Investment Trends 2022/2023 demonstrates that the pharmaceutical industry attracted the highest amount of FDI ($32 billion) between 2008 to 2021 - significantly more than investments in the medical devices ($20 billion), biotechnology ($17 billion) and healthcare ($10.8 billion) subsectors. This further increased the number of professional diagnostic centers providing comprehensive healthcare services.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others); and the Middle East and Africa. According to the report, North America was the largest market for point-of-care diagnostics.

North America boasts a highly developed healthcare infrastructure with well-established medical facilities, laboratories, and diagnostic centers. The robust healthcare system of the region enables widespread adoption and integration of POC diagnostics into routine medical practice, contributing to their market dominance. Besides this, the high prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, is driving the demand for comprehensive testing services. POC diagnostics play a crucial role in the early detection, monitoring, and management of these chronic conditions.

As per a press release by the Centers for Disease Control and Prevention, the number of Americans with diabetes will range between 1 in 3 to 1 in 5 by 2050. This will further increase the demand for point-of-care testing solutions in the region.

Competitive Landscape:

The competitive landscape of the market is dynamic and characterized by the presence of numerous players, including established companies, emerging startups, and specialized firms and effective in answering queries related to how big is the point-of-care diagnostics market? Major players are heavily investing in R&D to innovate and develop cutting-edge POC diagnostic solutions. They are also focusing on improving the accuracy, sensitivity, and speed of their tests. Top companies are expanding the range of analytes and diseases that can be detected using POC devices. R&D efforts also involve exploring new technologies, such as biosensors, microfluidics, and lab-on-a-chip systems, to enhance the performance of POC diagnostics. They are also tailoring their products and marketing strategies to meet the specific healthcare needs and regulatory requirements of different countries. For example, Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions as an addition to its product offerings. The point-of-care diagnostics market statistics indicate a robust expansion trajectory, fueled by rising demands for rapid testing, technological innovation, and a growing emphasis on decentralized healthcare.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Beckman Coulter, Inc.

Becton Dickinson and Company

F. Hoffmann-La Roche AG

Instrumentation Laboratory

Johnson & Johnson

Nova Biomedical Corporation

Pts Diagnostics

Qiagen

Siemens

Trinity Biotech

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

January 2023: Beckman Coulter, Inc. announced that it has entered a strategic partnership with MeMed to develop and commercialize a host immune response diagnostic test.

January 2023: Becton Dickinson and Company presented educational grant funding towards 19 to Zero for a point-of-care testing pilot in the primary care setting.

Key Questions Answered in This Report

  • 1. What is the global point-of-care diagnostics market growth?
  • 2. What are the global point-of-care diagnostics market drivers?
  • 3. What are the key industry trends in the global point-of-care diagnostics market?
  • 4. What is the impact of COVID-19 on the global point-of-care diagnostics market?
  • 5. What is the global point-of-care diagnostics market breakup by product type?
  • 6. What are the major regions in the global point-of-care diagnostics market?
  • 7. Who are the key companies/players in the global point-of-care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point-of-Care Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hematology Testing Kit
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dipsticks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microfluidics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Molecular Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Immunoassays
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 OTC Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Beckman Coulter Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Instrumentation Laboratory
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nova Biomedical Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pts Diagnostics
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Qiagen
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Siemens
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Trinity Biotech
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Point-of-Care Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point-of-Care Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Point-of-Care Diagnostics Market: Breakup by Product Type (in %), 2023
  • Figure 4: Global: Point-of-Care Diagnostics Market: Breakup by Platform (in %), 2023
  • Figure 5: Global: Point-of-Care Diagnostics Market: Breakup by Prescription Mode (in %), 2023
  • Figure 6: Global: Point-of-Care Diagnostics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Point-of-Care Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Point-of-Care Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Point-of-Care Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Point-of-Care Diagnostics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Point-of-Care Diagnostics (Dipsticks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Point-of-Care Diagnostics (Dipsticks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Point-of-Care Diagnostics (Microfluidics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Point-of-Care Diagnostics (Microfluidics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Point-of-Care Diagnostics (Immunoassays) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Point-of-Care Diagnostics (Immunoassays) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Point-of-Care Diagnostics (OTC Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Point-of-Care Diagnostics (OTC Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Point-of-Care Diagnostics (Home Care) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Point-of-Care Diagnostics (Home Care) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Point-of-Care Diagnostics (Research Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Point-of-Care Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Point-of-Care Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Point-of-Care Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: North America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: North America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: United States: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: United States: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Canada: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Canada: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Asia Pacific: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Asia Pacific: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: China: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: China: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Japan: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Japan: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: India: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: India: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: South Korea: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: South Korea: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Australia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Australia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Indonesia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Indonesia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Europe: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Europe: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Germany: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Germany: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: France: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: France: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: United Kingdom: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: United Kingdom: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Italy: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Italy: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Spain: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Spain: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Russia: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Russia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Latin America: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Latin America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Brazil: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Brazil: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Mexico: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Mexico: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Others: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Middle East and Africa: Point-of-Care Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Middle East and Africa: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Global: Point-of-Care Diagnostics Industry: SWOT Analysis
  • Figure 94: Global: Point-of-Care Diagnostics Industry: Value Chain Analysis
  • Figure 95: Global: Point-of-Care Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point-of-Care Diagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Platform (in Million US$), 2024-2032
  • Table 4: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Prescription Mode (in Million US$), 2024-2032
  • Table 5: Global: Point-of-Care Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Point-of-Care Diagnostics Market: Competitive Structure
  • Table 8: Global: Point-of-Care Diagnostics Market: Key Players